Prior work has identified RNASET2 as a susceptibility gene for IBD (30) and decreased RNASET2 expression has activating effects on pro-inflammatory cells, with an association with aggressive CD inflammation (31). This evidence concerns the gene RNASET2 and inflammatory bowel disease.